Woo Chul Kim Selected Research

Prostate-Specific Antigen (Semenogelase)

2/2017	Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancer.
12/2016	Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer.
3/2016	Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer.
12/2015	Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Woo Chul Kim Research Topics

Disease

6	Neoplasms (Cancer) 01/2024 - 12/2007
6	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 12/2015
3	Neoplasm Metastasis (Metastasis) 01/2024 - 08/2021
3	Breast Neoplasms (Breast Cancer) 02/2022 - 03/2020
3	Carcinoma (Carcinomatosis) 12/2021 - 09/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 10/2018
2	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2023
2	Margins of Excision 12/2021 - 09/2010
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 10/2019
1	Brain Neoplasms (Brain Tumor) 12/2023
1	Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation) 11/2023
1	Lymphedema (Milroy Disease) 06/2020
1	Ependymoma 01/2020
1	Astrocytoma (Pilocytic Astrocytoma) 07/2018
1	Hepatocellular Carcinoma (Hepatoma) 06/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2015
1	Tuberculosis (Tuberculoses) 11/2015
1	Endoleak 05/2014
1	Abdominal Aortic Aneurysm 05/2014
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2012
1	Embolism (Embolus) 12/2011
1	Thrombosis (Thrombus) 12/2011
1	Lymphatic Metastasis 09/2010
1	Residual Neoplasm 09/2010

Drug/Important Bio-Agent (IBA)

4	Prostate-Specific Antigen (Semenogelase)IBA 02/2017 - 12/2015
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 10/2019
2	R-CHOP protocolIBA 01/2020 - 10/2019
2	Rituximab (Mabthera)FDA Link 01/2020 - 10/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 10/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 10/2019
2	Prednisone (Sone)FDA LinkGeneric 01/2020 - 10/2019
1	CarbohydratesIBA 01/2024
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2024
1	mutacin GS-5 (GS 5)IBA 03/2016
1	AndrogensIBA 12/2015

Therapy/Procedure

20	Radiotherapy 12/2023 - 09/2003
5	Drug Therapy (Chemotherapy) 12/2021 - 12/2011
4	Adjuvant Radiotherapy 02/2022 - 12/2007
4	Therapeutics 12/2021 - 11/2015
2	Re-Irradiation 01/2020 - 01/2020
1	Palliative Care (Palliative Therapy) 01/2023
1	Chemoradiotherapy 12/2021
1	Adjuvant Chemoradiotherapy 12/2021
1	Prostatectomy (Retropubic Prostatectomy) 08/2021
1	Segmental Mastectomy (Lumpectomy) 06/2020
1	Adjuvant Chemotherapy 03/2020
1	Conformal Radiotherapy 03/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2020
1	Aftercare (After-Treatment) 11/2015
1	Stents 05/2014
1	Endovascular Aneurysm Repair 05/2014
1	Craniospinal Irradiation 11/2012
1	Thrombectomy 12/2011
1	Catheters 12/2011
1	Brachytherapy 09/2003